Internal Medicine, Cardiovascular Disease · New York, NY
NPI
1740664085
Since 2015
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1 Gustave L Levy Pl
New York, NY, 10029
Phone (212) 427-1540
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
477 services
Medicare patients, 2024
126
Average age 73
Drug cost, 2024
$4.4M
563 prescriptions
Company payments, 2025
$14K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria Giovanna Trivieri was code 99233 (hospital e&m - subsequent), 147 times for 51 patients. In total Maria Giovanna Trivieri billed 477 services in 20 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 147 | 51 | $102.12 | $15K |
| 99215 Office E&M - Established | Facility | 127 | 60 | $118.02 | $15K |
| 99291 Critical Care E&M | Facility | 73 | 19 | $185.22 | $14K |
| 93750 External Electrocardiographic Monitoring | Facility | 51 | 12 | $35.41 | $1,806 |
| 93010 Electrocardiogram | Facility | 35 | 30 | $6.98 | $244 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $110.68 | $1,218 |
By year: 2022 $41K for 344 services; 2023 $48K for 453 services; 2024 $50K for 477 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria Giovanna Trivieri prescribed most often to Medicare patients was Adempas (Riociguat), with 130 prescriptions and refills. In total Maria Giovanna Trivieri wrote 563 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Adempas Riociguat | 130 | 130 | 20 | $1.8M |
| Ambrisentan Generic | 69 | 69 | 11 | $227K |
| Tadalafil Generic | 53 | 57 | Under 11 | $62K |
| Opsumit Macitentan | 53 | 53 | Under 11 | $685K |
| Uptravi Selexipag | 40 | 40 | Under 11 | $887K |
| Orenitram Er Treprostinil Diolamine | 18 | 18 | Under 11 | $449K |
| Atorvastatin Calcium Generic | 16 | 47 | Under 11 | $240 |
| Sildenafil Citrate Generic | 14 | 14 | Under 11 | $5,882 |
| Metoprolol Succinate Generic | 13 | 19 | Under 11 | $85.23 |
| Tracleer Bosentan | 13 | 13 | Under 11 | $154K |
| Furosemide Generic | 11 | 27 | Under 11 | $107 |
| Digoxin Generic | 11 | 24 | Under 11 | $106 |
Brand drugs: 288 claims; generic drugs: 275 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria Giovanna Trivieri $14K ($14K in general payments such as food, travel and fees) from 16 companies. The largest payer was Pfizer Inc. with $9,192.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 8 | $9,192 |
| Actelion Pharmaceuticals US, Inc. JNJ | 6 | $3,279 |
| United Therapeutics Corporation UTHR | 2 | $259 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $253 |
| Alnylam Pharmaceuticals Inc. ALNY | 4 | $235 |
| CVRx, Inc. CVRX | 2 | $162 |
| Abbott Laboratories ABT | 1 | $140 |
| Abiomed JNJ | 2 | $112 |
| Merck Sharp & Dohme LLC MRK | 3 | $75.26 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $43.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.